The data of an immunotherapy cohort from MSKCC (16) were used as a discovery cohort (NSCLC, n = 266, PAK7-MT vs PAK-WT =13:253) in which the patients received inhibitors of PD-1 or PD-L1. The gene discussed is CD274; the disease is non-small cell lung carcinoma.